BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31591260)

  • 1. Molecular Pharmacology of Class F Receptor Activation.
    Kozielewicz P; Turku A; Schulte G
    Mol Pharmacol; 2020 Feb; 97(2):62-71. PubMed ID: 31591260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insight into small molecule action on Frizzleds.
    Kozielewicz P; Turku A; Bowin CF; Petersen J; Valnohova J; Cañizal MCA; Ono Y; Inoue A; Hoffmann C; Schulte G
    Nat Commun; 2020 Jan; 11(1):414. PubMed ID: 31964872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Union of Basic and Clinical Pharmacology. LXXX. The class Frizzled receptors.
    Schulte G
    Pharmacol Rev; 2010 Dec; 62(4):632-67. PubMed ID: 21079039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Druggability Landscape of Frizzled G Protein-Coupled Receptors.
    Zhang X; Dong S; Xu F
    Trends Biochem Sci; 2018 Dec; 43(12):1033-1046. PubMed ID: 30309741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residue 6.43 defines receptor function in class F GPCRs.
    Turku A; Schihada H; Kozielewicz P; Bowin CF; Schulte G
    Nat Commun; 2021 Jun; 12(1):3919. PubMed ID: 34168128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopamine.
    Kozielewicz P; Bowin CF; Turku A; Schulte G
    Mol Pharmacol; 2020 Jan; 97(1):23-34. PubMed ID: 31707356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signalling.
    Rana R; Carroll CE; Lee HJ; Bao J; Marada S; Grace CR; Guibao CD; Ogden SK; Zheng JJ
    Nat Commun; 2013; 4():2965. PubMed ID: 24351982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
    Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
    Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Basic and Clinical Pharmacology. CXV: The Class F of G Protein-Coupled Receptors.
    Schulte G
    Pharmacol Rev; 2024 Jul; ():. PubMed ID: 38955509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoothened stimulation by membrane sterols drives Hedgehog pathway activity.
    Deshpande I; Liang J; Hedeen D; Roberts KJ; Zhang Y; Ha B; Latorraca NR; Faust B; Dror RO; Beachy PA; Myers BR; Manglik A
    Nature; 2019 Jul; 571(7764):284-288. PubMed ID: 31263273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3.
    Dijksterhuis JP; Petersen J; Schulte G
    Br J Pharmacol; 2014 Mar; 171(5):1195-209. PubMed ID: 24032637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employing Genetically Encoded, Biophysical Sensors to Understand WNT/Frizzled Interaction and Receptor Complex Activation.
    Kozielewicz P; Schihada H; Schulte G
    Handb Exp Pharmacol; 2021; 269():101-115. PubMed ID: 34463848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insight into Class F receptors - What have we learnt regarding agonist-induced activation?
    Schulte G; Kozielewicz P
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():17-24. PubMed ID: 30925000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structure of oxysterol-bound human Smoothened coupled to a heterotrimeric G
    Qi X; Liu H; Thompson B; McDonald J; Zhang C; Li X
    Nature; 2019 Jul; 571(7764):279-283. PubMed ID: 31168089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of Smoothened for therapeutic gain.
    Ruat M; Hoch L; Faure H; Rognan D
    Trends Pharmacol Sci; 2014 May; 35(5):237-46. PubMed ID: 24703627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity.
    Kilander MB; Dahlström J; Schulte G
    Cell Signal; 2014 Sep; 26(9):1943-9. PubMed ID: 24873871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation mechanism of the human Smoothened receptor.
    Bansal PD; Dutta S; Shukla D
    Biophys J; 2023 Apr; 122(7):1400-1413. PubMed ID: 36883002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of Patched, Smoothened and cholesterol in Hedgehog signaling.
    Hu A; Song BL
    Curr Opin Cell Biol; 2019 Dec; 61():31-38. PubMed ID: 31369952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
    Zhang H; Sun Z; Liu Z; Song C
    Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
    Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
    FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.